Policy Pulse — Global — 31 Jul 2026

🌍 Global Spillover — Pharma Tariffs Go Live, Energy-Security Capex, Market Stabilization

Today's global picture is defined by: (1) US Section 232 pharma tariffs taking effect (branded protected, generics exempt — a relief for Indian generics), (2) India's Samudra Manthan + PM-SSY energy-security capex as a major Indian policy signal, and (3) continued market stabilization after the Fed's yield shock, with crude easing and global risk appetite recovering.

🇺🇸 US Pharma Section 232 Tariffs Effective Jul 31

What happened: 100% duties on patented branded drugs and APIs from 17 named companies took effect today. Generics/biosimilars exempt. Tiered: EU/Japan/Korea 15%, UK 10%. 20% onshoring incentive for companies moving production to US. Sept 29 deadline for all other importers.

StockImpactCountryReason
LLY🟢 Positive🇺🇸 USBranded pharma protected from import competition
MRK🟢 Positive🇺🇸 USBranded innovator — structural tariff wall positive
JNJ🟢 Positive🇺🇸 USDiversified branded pharma insulated
PFE🟢 Positive🇺🇸 USInnovator drugs — protected
ABBV🟢 Positive🇺🇸 USBranded specialty — benefits from generic entry barrier
NAVI🟡 Hold🇮🇳 IndiaDiversified — limited direct exposure

🇮🇳 Samudra Manthan — ₹84,084 Cr Offshore Exploration (India Energy Security)

What happened: Cabinet approved the National Offshore Exploration Scheme — deepwater/ultra-deepwater drilling, seismic acquisition, frontier-basin scientific wells, up to FY 2030-31. Direct response to Hormuz-driven import-dependence risk. Beneficiaries dominated by ONGC/OIL.

StockImpactCountryReason
ONGC🟢 Positive🇮🇳 IndiaMost direct beneficiary — first deepwater well already spudded under scheme
OIL🟢 Positive🇮🇳 IndiaOffshore acreage expansion under OALP
XOM🟡 Hold🇺🇸 USGlobal oil majors may participate in Indian basins — tangential

Confirmed: Nifty Oil & Gas +1% today — ONGC/OIL led the energy-security move.

🇮🇳 PM-SSY Floating Solar + Storage — Global Renewable Themes

What happened: ₹5,070 cr for 5,000 MW floating solar + 10,000 MWh storage. Reinforces the global push toward solar-plus-storage as the default dispatchable-renewable model.

StockImpactCountryReason
TATAPOWER🟢 Positive🇮🇳 IndiaFSPV capability + large renewable pipeline
SJVN🟢 Positive🇮🇳 IndiaHydro/waterbody developer — natural floating-solar fit
NHPC🟢 Positive🇮🇳 IndiaLarge waterbody developer, ESS-ready
EXIDEIND🟢 Positive🇮🇳 India10,000 MWh storage mandate — battery beneficiary
AMARAJABAT🟢 Positive🇮🇳 IndiaEnergy storage exposure
FSLR🟡 Hold🇺🇸 USGlobal floating-solar tech benchmark — sector read-through

📉 Market Stabilization — Crude Eases, Equities Recover After Fed Shock

What happened: After the Jul 29 Fed hawkish hold sent 30-yr yields to 2007 highs, markets stabilized going into week's end. Easing crude (off the $90 Hormuz spike) and a strengthening rupee (3-week high ~95.4/$) underpinned a third straight up day for Indian indices. Nifty IT was the laggard (-1.5%), auto led (+1.6%).

StockImpactCountryReason
SPY🟡 Hold🇺🇸 USStabilizing — watch Sept FOMC for direction
QQQ🟡 Hold🇺🇸 USTech steady as crude eases but yields elevated
XOM🟡 Hold🇺🇸 USCrude easing off highs — oil gains partial
M&M🟢 Positive🇮🇳 IndiaAuto momentum, top Nifty gainer
COALINDIA🟢 Positive🇮🇳 IndiaTop Nifty gainer — energy/value bid

Summary

Three global themes for today: (1) US pharma Section 232 tariffs live → BUY branded (LLY, MRK, JNJ, PFE, ABBV), generics exempt (relief for SUNPHARMA, DRREDDY, CIPLA); (2) India's Samudra Manthan energy-security capex → BUY ONGC, OIL; (3) market stabilization after the Fed yield shock with oil easing and risk appetite recovering. Indian markets logged a third straight up day (Nifty 24,384) on FII buying and easing crude.

For Indian markets: Energy security (ONGC, OIL) and floating-solar/storage (TATAPOWER, SJVN, NHPC, EXIDEIND) are the day's clearest policy-driven signals, alongside pharma-generics relief.

For US markets: Branded pharma remains the strongest structural policy beneficiary into the Sept 29 expansion.